Wiaczeslaw Smolokowski's Net Worth
$0
Estimate Recalculated Nov 7, 2024 12:13PM EST
Who is Wiaczeslaw Smolokowski?
Wiaczeslaw Smolokowski does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Karyopharm Therapeutics Inc., and Acrivon Therapeutics, Inc..
SEC CIK
Wiaczeslaw Smolokowski's CIK is 0001591274
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $0.77
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.43% | -149.62K |
$4.14 | -$619,114.19 | 6M |
Feb 28
| |||
Form 4
| -19.42% | -1.48M |
$4.81 | -$7,127,923.51 | 6.15M |
Feb 25 - Feb 27
| |||
Form 4
| -2.11% | -164.80K |
$21.05 | -$3,468,729.92 | 7.63M |
Sep 5 - Sep 6
| |||
Form 4
| -3.12% | -251.47K |
$20.94 | -$5,265,367.67 | 7.8M |
Aug 30 - Sep 4
| |||
Form 4
| -2.59% | -214.03K |
$19.52 | -$4,178,055.55 | 8.05M |
Aug 27 - Aug 29
| |||
Form 4
| -0.01% | -702.00 |
$18.50 | -$12,987.00 | 8.26M |
Aug 10
| |||
Form 4
| -0.97% | -80.88K |
$18.52 | -$1,498,077.48 | 8.26M |
Aug 7 - Aug 9
| |||
Form 4
| -0.36% | -30.04K |
$18.65 | -$560,134.76 | 8.34M |
Jul 23 - Jul 25
| |||
Form 4
| -1.49% | -126.74K |
$18.97 | -$2,403,744.74 | 8.37M |
Jul 19 - Jul 20
| |||
Form 4
| -0.58% | -50.00K |
$18.52 | -$926,066.84 | 8.5M |
Jul 16 - Jul 18
| |||
Form 4
| -0.22% | -18.82K |
$8.03 | -$151,083.31 | 8.55M |
Jun 23
| |||
Form 4
| -0.08% | -7.07K |
$8.51 | -$60,213.89 | 8.57M |
Jun 13
| |||
Form 4
| -0.53% | -45.54K |
$9.21 | -$419,283.58 | 8.58M |
Jun 8 - Jun 9
| |||
Form 4
| -0.46% | -40.00K |
$9.24 | -$369,550.00 | 8.62M |
Jun 6 - Jun 7
| |||
Form 4
| -0.21% | -17.86K |
$9.65 | -$172,243.61 | 8.66M |
Jun 2
| |||
Form 4
| -0.85% | -74.66K |
$9.61 | -$717,599.55 | 8.68M |
May 27 - Jun 1
| |||
Form 4
| -0.52% | -46.12K |
$9.73 | -$448,828.43 | 8.75M |
May 25 - May 26
| |||
Form 4
| -1.06% | -93.93K |
$8.54 | -$801,805.98 | 8.8M |
May 19 - May 23
| |||
Form 4
| -0.71% | -63.80K |
$8.15 | -$519,968.14 | 8.89M |
May 17 - May 18
| |||
Form 4
| -0.12% | -10.40K |
$8.01 | -$83,268.48 | 8.96M |
May 13 - May 16
| |||
Form 4
| -0.35% | -31.87K |
$8.24 | -$262,647.73 | 8.97M |
May 10 - May 11
| |||
Form 4
| -2.95% | -278.12K |
$42.09 | -$11,658,660.36 | 9.14M |
Nov 26 - Dec 1
| |||
Form 4
| -2.52% | -242.80K |
$42.40 | -$10,294,047.64 | 9.41M |
Nov 21 - Nov 25
| |||
Form 4
| -0.68% | -65.97K |
$40.09 | -$2,644,791.45 | 9.65M |
Nov 18 - Nov 19
| |||
Form 4
| -1.68% | -164.10K |
$42.83 | -$7,028,026.93 | 9.59M |
Nov 10 - Nov 12
| |||
Form 4
| -2.72% | -272.78K |
$42.11 | -$11,488,163.78 | 9.75M |
Nov 4 - Nov 6
| |||
Form 4
| -1.96% | -200.00K |
$42.65 | -$8,529,201.50 | 10.02M |
Sep 26
| |||
Form 4
| -0.04% | -4.31K |
$41.12 | -$177,325.39 | 10.22M |
Sep 12
| |||
Form 4
| -0.29% | -30.00K |
$35.20 | -$1,055,853.00 | 10.23M |
Jul 29
| |||
Form 4
|
∞
| 20.52M |
—
|
—
| 20.52M |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acrivon Therapeutics, Inc. (ACRV) Snapshot price: $8.08
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.00% | -16.00 |
$12.93 | -$206.88 | 3.85M |
Jun 26
| |||
Form 4
| -0.05% | -2.06K |
$12.14 | -$24,959.84 | 3.85M |
Jun 15
| |||
Form 4
| -0.15% | -5.89K |
$12.29 | -$72,412.09 | 3.85M |
Jun 12 - Jun 14
| |||
Form 4
| +50.00% | 3.86M |
$12.50 | $5,000,000.00 | 11.57M |
Nov 17
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||